
IMMATICS NV- WARRANTS
Share · NL0015285958 · IMTXW (XNAS)
0,02 USD
09.06.2025 17:52
Current Prices from IMMATICS NV- WARRANTS
Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
---|---|---|---|---|---|
![]() NASDAQ |
IMTXW
|
USD
|
09.06.2025 17:52
|
0,02 USD
| 0,03 USD
-39,20 %
|
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
-39,20 % | -47,59 % | 9,35 % | -53,74 % | -95,89 % | -99,59 % | -99,72 % |
Company Profile for IMMATICS NV- WARRANTS Share
Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive cell therapies (ACT) and antibody-like TCR Bispecifics. Its products pipeline includes IMA203 that targets solid tumors, which is in Phase 1b clinical trial; IMA203CD8, a cell therapy product that is in Phase 1b clinical trial; IMA204 that targets tumor stroma, which is in preclinical stage; and IMA30x, an allogenic cellular therapy product candidate, which is in preclinical stage. The company also develops TCR Bispecifics products, including IMA401, which is in Phase 1b clinical trial; and IMA402 and IMA403, which are in preclinical stages. The company has a strategic collaboration agreement with MD Anderson Cancer Center to develop multiple T cell and TCR-based adoptive cellular therapies; Celgene Corporation to develop novel adoptive cell therapies targeting multiple cancers; and Genmab A/S to develop T cell engaging bispecific immunotherapies targeting multiple cancer indications. Immatics N.V. is headquartered in Tübingen, Germany.
Company Data
Name IMMATICS NV- WARRANTS
Company immatics biotechnologies GmbH
Symbol IMTXW
Website
https://www.immatics.com
Primary Exchange
NASDAQ

ISIN NL0015285958
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Dr. Harpreet Singh Ph.D.
Market Capitalization 387 Mio
Country United States of America
Currency USD
Employees 0,6 T
Address Paul-Ehrlich-Strasse 15, 72076 Tübingen
IPO Date 2020-07-02
Ticker Symbols
Name | Symbol |
---|---|
NASDAQ | IMTXW |
More Shares
Investors who IMMATICS NV- WARRANTS hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.